clinical
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The […] The post vVARDIS Announces Investment from Apollo—Achieves Unicorn Status appeared first on Dentistry Today.
By Dentistry Today ·
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The […]
The post vVARDIS Announces Investment from Apollo—Achieves Unicorn Status appeared first on Dentistry Today.